Trial Profile
Randomized Trial of the Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Acute Gastroenteritis in a Pediatric Emergency Department
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Gastroenteritis; Vomiting
- Focus Therapeutic Use
- 05 Dec 2011 New trial record